Israel, Under Pressure From Generics Industry, Delays Changes To Patent Law

Law360, New York (April 25, 2004, 12:00 AM EDT) -- Israel’s government, under intense pressure from the country’s generic drug industry, has postponed proposed amendments to the patent law demanded by U.S. officials.

Minister of Industry and Deputy Prime Minister Ehud Olmert told local media that he has postponed the introduction of the changes, and that his ministry is negotiating with the U.S. to prevent the listing of Israel as a violator of intellectual property rights.

Olmert’s decision came after lobbying from the Israeli pharmaceutics industry, led by Teva, according to local sources. Last week, Teva...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.